NCT02131766COMPLETEDanonymous

Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Overnight Control in Type 1 Diabetes

Sponsor

Source record

University of Virginia

Phase

Source record

Modality

AI-normalized

cell therapy

Target

AI-normalized

Type 1 Diabetes

Indication / condition

AI-normalized

Diabetes Mellitus

Intervention

Source record

DiAs, Sensor Augmented Pump Therapy

Related intelligence directories

Indication directory: Diabetes Mellitus Modality directory: cell therapy Target directory: Type 1 Diabetes

Source & freshness

Source record

NCT ID

NCT02131766

Original source

ClinicalTrials.gov

Source last updated

Apr 16, 2020

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT02131766

Title

Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Overnight Control in Type 1 Diabetes

Sponsor

University of Virginia

Status

COMPLETED

Phase

Condition raw

Diabetes Mellitus

Condition normalized

Diabetes Mellitus

Modality raw

Diabetes Mellitus

Modality normalized

cell therapy

Target raw

Type 1 Diabetes

Target normalized

Type 1 Diabetes

Interventions

DiAs, Sensor Augmented Pump Therapy

Public preview

Source record

The USS Virginia Closed-Loop system aims to improve overnight blood glucose control in adults with Type 1 Diabetes (T1DM) compared to traditional sensor-augmented pump therapy. The study evaluates the feasibility and effectiveness of this system in an outpatient setting.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Overnight Control in Type 1 Diabetes

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT02131766

Status

COMPLETED

Phase

Sponsor

University of Virginia

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedApr 16, 2020

Internal syncJun 05, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02131766

Indication

Diabetes Mellitus

Modality

cell therapy

Target

Type 1 Diabetes

Intervention

DiAs, Sensor Augmented Pump Therapy

Source record